Palo Alto’s Kodiak Sciences just turned down a $125M investment. Here’s why.

//Palo Alto’s Kodiak Sciences just turned down a $125M investment. Here’s why.

Palo Alto’s Kodiak Sciences just turned down a $125M investment. Here’s why.

The move signaled how easy it is these days for biotechnology companies to raise cash.

Article by [author-name] (c) Health Care News - Health Care News Headlines | Bizjournals.com - Read full story here.

By | 2021-07-24T00:37:39+00:00 July 24th, 2021|Healthcare|

About the Author: